main results: For both promoters, high methylation was observed in sperm cells. Although, in general, the promoters were unmethylated in oocytes, the methylation of some alleles was observed, particularly in oocytes from women with known infertility. Both gene promoters were hypomethylated in control blastocyst ICM (inner cell mass) and in control 2-8-cells embryos obtained from 6 out of 8 couples. However, they appeared highly methylated in embryos obtained from the other two couples. In most arrested ICSI embryos, the Nanog promoter was unmethylated while the Oct4 promoter was highly methylated. High methylation of the Oct4 promoter was significantly more pronounced in embryos from couples where a male factor was the only known cause of infertility. When the embryos were heterozygous for a G/A single nucleotide polymorphism, both alleles could be methylated, each likely representing a paternally inherited or a maternally inherited copy.
Introduction
Cytosine methylation plays important roles in key biological processes, and as a general rule, methylation of gene promoters is associated with gene silencing (Weber et al., 2007) . During mammalian development, there are two waves of genome-wide reprogramming of DNA methylation, one in developing primordial germ cells, the other one after fertilization in the early embryo (Reik, 2007; Surani et al., 2007) . An asymmetric demethylation targeting the paternal genome seems to occur soon after fertilization, independent of DNA replication Oswald et al., 2000; Santos et al., 2002; Reik, 2007) , while the maternal genome undergoes passive demethylation during DNA replication in cleavage-stage embryos (Reik, 2007; Surani et al., 2007) . A possible explanation for demethylation in the early embryo is that the parental genomes have to lose their epigenetic marks so that the embryonic genome can return to pluripotency (Reik et al., 2001) . Several transcription factors such as Nanog and Oct4 play critical roles in the establishment and maintenance of pluripotency during normal early embryonic development (Nichols et al., 1998; Niwa et al., 2000; Chambers et al., 2003; Mitsui et al., 2003) . The homeobox transcription factor Nanog is essential for the embryonic versus extraembryonic endoderm lineage decision, it blocks the differentiation into primitive endoderm (Mitsui et al., 2003) while the POU domain transcription factor Oct4 prevents the differentiation of the inner cell mass (ICM) into trophectoderm (Nichols et al., 1998; Niwa et al., 2000) . The expression of Nanog and Oct4 are negatively regulated through the methylation of their promoters in the mouse (Farthing et al., 2008; Fouse et al., 2008) as well as in humans (Deb-Rinker et al., 2005) .
In the mouse, the Nanog promoter is unmethylated in oocytes, while heavily methylated in sperm, and a rapid demethylation of the paternal copy occurs immediately after fertilization; the Nanog promoter is unmetylated in the morula when its expression begins (Farthing et al., 2008) . The Oct4 promoter is partially methylated in mouse sperm and unmethylated in oocytes and normal 8-cell and blatocyst embryos. However, it appears highly methylated in cloned embryos up to the 8-cell stage (Yamazaki et al., 2006) . Nuclear transplantation experiments have shown that oocyte can demethylate the Oct4 promoter and that this demethylation precedes Oct4 transcription (Simonsson and Gurdon, 2004) . Thus, the reprogramming of key pluripotency genes appears crucial for the transmission of pluripotency which allows normal development to occur.
Comparative studies on two types of MII mouse oocytes showed that the one that ceases development at 2-cell stage showed downregulation of Oct4 compared with the one which could support the development of the embryo to term (Zuccotti et al., 2008) .
In humans, a high percentage of embryos obtained by in vitro fertilization does not reach the blastocyst stage because of the blocking of development at the time of zygotic gene activation. While Nanog and Oct4 promoters appeared heavily methylated in the sperm (Hammoud et al., 2009) , their methylation status in oocytes and early embryos is not yet documented.
The goal of this study was thus to evaluate the methylation status of Nanog and Oct4 promoters in human sperm from fertile men, as well as in human oocytes from stimulated ovaries and in human preimplantation ICSI embryons in relation to their capacity to accomplish normal development.
Materials and Methods

Source of human embryos and gametes
A total of 45 arrested ICSI embryos obtained from 28 different couples were analysed. Most of these embryos were only at the 2-cell stage after 48 h of culture and remained arrested at 2-to 8-cell stages after prolonged culture. A total of 21 control ICSI embryos which developed normally and mostly reached the 4-cell stage at Day 2 were utilized as well as 7 control blastocyts. Those were from 14 different couples and were cryopreserved for 10 -11 years before donation. Indications for ICSI, according to the WHO criteria, are given in Supplementary data, Table S1 . The control and arrested embryos were donated for research by patients of the Department of Reproductive Medecine at the Hô pital Femme Mère Enfant (Bron, France) and the Clinique du Tonkin (Villeurbanne, France) after giving their informed consent. Protocols were approved by the Agence de la Biomédecine, the French legal institution for research on human embryos. The zona pellucida and attached cumulus cells were removed from 2-to 8-cell embryos by digestion with 9 units/ml proteinase K (Euromedex, France) for 1 min. Denuded embryos were carefully examined under an inverted microscope with Hoffman Modulation Contrast optics (DM IRB, Leica, Nanterre, France) and only cumulus cell-free embryos were selected for analysis and individually stored at 2808C. The zona pellucida was first removed from high-quality control blastocysts by incubation in 2 -3 min with 10 units/ml pronase (Sigma-Aldrich, Saint Quentin Fallavier, France) at room temperature. Zona-free blastocyts were transferred to phosphate-buffered saline 1% BSA. ICMs that were composed of compacted, tightly adhered together cells were mechanically isolated with the help of two fine glass needles and gentle pipetting under a zoom stereomicroscope (Leica; Yu et al., 2008) .
Control sperm correspond to sperm of five normally fertile men. After liquefaction, ejaculates were centrifugated at 300g during 20 min on a discontinuous 3-layer density gradient (PureSperm, Nicadon, Gothenberg, Sweden; 90, 70 and 50%) in order to eliminate somatic cell contamination and select a high quality sperm fraction. The higher density fraction (90%) was washed with Ferticult flushing medium (FertiPro N.V., Beernem Belgium), then centrifugated at 600g during 10 min, finally the sperm pellet was resuspended in Universal IVF medium (Origio, Denmark) and DNA was extracted by a standard method. A total of 70 oocytes from stimulated ovaries were utilized in this study, after obtaining the informed consent of the patients. At the time of retrieval, they were immature at late MI stage and they were not fertilized. They were kept in the IVM medium until they reached the metaphase II (MII) stage within the next 4 h. They were divided into two groups, first group consisted of 46 oocytes from 20 different women with known infertility and the second group consisted of 24 oocytes from 11 couples where a male factor was the only known cause of infertility (for indications, see Supplementary data, Table S2 ). The zona pellucida and any remaining somatic cells were removed by digestion with proteinase K (9 units/ml). After careful examination under an inverted microscope with Hoffman Modulation Contrast optics (Leica DM IRB), only cumulus-free oocytes were selected for analysis.
DNA methylation analysis
The methylation profiles of Nanog and Oct4 promoters were determined by bisulphite mutagenesis and sequencing as previously described (Borghol et al., 2008) . The DNA was extracted with the Nucleospin w Blood kit for lymphocytes and with the Nucleospin w Tissue kit for sperm, both from Macherey-Nagel (Hoerdt, France). Bisulphite treatment was achieved with the EpiTect Plus LyseAll Bisulfite Kit by Qiagen (Les Ulis, France), according to the manufacturer recommendations. Prior to bisulphite treatment, zona-free embryos and oocytes were directly incubated in the kit lysis buffer.
The bisulphite-modified DNA was subjected to duplex-nested PCR. We analysed 10 CpG sites in a 209 bp fragment of Oct4 promoter harbouring a single nucleotide polymorphism G/A at nucleotide 21, and 8 CpG sites in a 290-bp fragment of Nanog promoter. Primers specific for bisulphite-converted DNA were the followings: for Oct4, external forward:
′ . Four to eight independent nested PCRs were performed per sperm sample, oocyte pools, lymphocytes and control ICMs. A single-nested PCR was performed per 2 -8-cell embryos. The PCR products were subcloned into pGEM-T plasmid (Promega, Charbonnières les Bains, France). Five clones were sequenced for each PCR product (Biofidal, Lyon, France) when several PCR were performed, and 10 clones when only 1 PCR was performed, for 2 -8-cell embryos.
Statistics
Statistical analyses were done using the non-parametric Kendall's rank correlation test; P ≤ 0.05 was considered statistically significant. To compute the significance of altered methylation in arrested embryos compared with control embryos, we used x 2 analysis and a P value ≤0.05 was considered significant.
Results
Because of the small number of DNA molecules available for amplification in a single embryo or in an oocyte pool, identical sequences obtained from the same PCR product are counted only once, since they may result from the amplification of the same DNA fragment, as previously discussed (Borghol et al., 2008) . Nanog and Oct4 promoters were highly methylated in lymphocytes, up to 97.6 and 71.2%, respectively and in sperm cells, up to 96 and 97.8%, respectively as shown in Fig. 1B . As expected, both promoters were almost unmethylated (8.4 and 10.5% methylation for Nanog and Oct4, respectively) in ICM cells from control blastocysts (Fig. 1B) . Control blastocysts were from six different couples, the women being 34.8 years old + 3.2; infertility indications are given in Supplementary data, Table S1 . Human oocytes were obtained from women who underwent hormonal stimulation in an ICSI programme. They were immature at late MI stage at the time of retrieval and they reached the MII stage in vitro within the next 4 h. They were divided into two groups, the first group consisted of 46 oocytes from 20 women (33.8 years old + 3) with different female infertility indications (Supplementary data, Table S2 ). The second group consisted of 24 oocytes from couples with only male infertility indications (33.5 years old + 3.8). In oocytes from the first group, both Nanog and Oct4 promoters were significantly (P , 0.0001) more methylated than in oocytes from the second: Nanog 34.6 versus 22.2%, respectively, (88 methylated CpGs over 256 analysed versus 32 methylated CpGs over 144 analysed); Oct4 40 versus 24.6%, respectively (144 methylated CpGs over 285 analysed versus 32 methylated CpGs over 130 analysed). The results suggest that a correlation may exist between PCOs (polycystic ovary syndrome) and the methylation of Oct4 promoter in oocytes (Supplementary data, additional information S1), but the small number of oocyte pools analysed does not permit statistical significance to be asserted. A single polymorphism (SNP) CG/CA was observed at nucleotide +21 (Fig. 1A) . Thus in embryos where both type of alleles are found, one is likely to be inherited from the father and the other one from the mother.
Control 4-cell embryos were ICSI embryos which normally reached this stage at Day 2, regardless of their capacity to further develop to the blastocyst stage, and which were cryopreserved for 10 -11 years.
A total of 21 4-cell control embryos from eight different couples, with various infertility factors (see Supplementary data, Table S1), were analysed; women were 31 + 2.9 (mean + SEM) years old. Nanog and Oct4 could be jointly analysed in 13 embryos. In the remaining embryos, Oct4 alone could be analysed in three embryos and Nanog alone in five embryos as shown in Supplementary data, additional information S1. In embryos obtained from six couples (Fig. 2A, Group 1 ; Supplementary data, additional information S2), both promoters were hypomethylated, from 0 to 31.2% for Nanog and from 0 to 26.1% for Oct4. In embryos obtained from couples 3 and 8 ( Fig. 2A, Group 2 ; Supplementary data, additional information S2), both promoters were highly methylated, 84.4 and 57.1%, respectively, for Nanog and 64.9 and 89.2% for Oct4. Seven embryos were heterozygous for the SNP G/A base 21. Three of them (C2.1, C4.1, C4.2) exhibited hypomethylation at both allele type, 21G or 21C, while in embryo C3.1 and C8.1, the alleles bearing the SNP G or A are both highly methylated, though one type is likely to be inherited from the father and the other one from the mother.
We analysed 45 embryos that did not reach the blastocyst stage, from 28 different couples [women were 31 + 3.4 (mean + SEM) years old]. They were arrested at 2-to 8-cell stages. The causes of infertility varied: 9 were male, 9 female, 10 were both female and male and 2 were unknown, as shown in Supplementary data, Table  S1 . Nanog and Oct4 could be jointly analysed in 21 embryos, Nanog alone in 9 embryos and Oct4 alone in 15 embryos. The Nanog promoter was hypomethylated in 26 embryos (3.66% methylated CpGs) out of 30 analysed, the other 4 being methylated from 37.5 up to 75% (Fig 2B; Supplementary data, additional information S3). The Oct4 promoter was hypomethylated (2.9% methylated CpGs) in only 7 embryos out of 36 analysed, the other 29 being methylated from 32.1 up to 96.6% (Fig 2B; Supplementary data, additional information S3). As seen for control embryos, within the 14 embryos exhibiting the two types of alleles, CG or TA, a few showed high methylation on both types (n, 151, 158), suggesting hypermethylation of both parental alleles. The Oct4 promoter appeared significantly more methylated (P , 0.0001) in embryos from the population of couples with only male known infertility compared with embryos from the population of couples with only female known infertily (Fig. 2C) .
Compared with control embryos, embryos with developmental failure appeared more likely to show highly methylated Oct4 promoters (29/36 versus 6/16, P , 0.01).
Discussion
In the present study, we have shown that in human sperm cells Nanog and Oct4 promoters are both highly methylated, while in oocytes they are hypomethylated. Hypermethylation of Oct4 and Nanog has been previously observed in human sperm by Hammoud et al. (2009) . In mouse, Nanog was also highly methylated in sperm (Farthing et al., 2008) , while Oct4 appeared only mildly methylated (Yamazaki et al., 2006) . For both genes, we observed residual methylation in some oocytes and this was more pronounced when they belonged to pools from women with known infertility. The human Nanog promoter region shares a homology with the mouse upstream region (Chambers and Smith, 2004) and the Oct4 regulatory region is also highly conserved among species (Kobolak et al., 2009 ). In the mouse oocyte, both gene promoters are almost unmethylated (Yamazaki et al., 2006; Farthing et al., 2008) . The mouse oocytes used in those studies were in vivo matured MII oocytes from presumably fertile females while the human oocytes analysed in this study were from unfertile couples. However, even in the case where no female infertility factor was detected in our patients, the corresponding oocytes may bear unknown defects, particularly of an epigenetic nature. Furthermore, these human oocytes were retrieved from stimulated cycles, they were immature at the time of retrieval and they only reached the MII stage in vitro. We previously showed that the hormonal induction of ovulation led to the release of MII oocytes carrying incomplete imprint at KCNQ1OT1 (Khoueiry et al., 2008) and that in vitro matured oocytes exhibited abnormal methylation of H19 DMR (Borghol et al., 2008) . In addition, infertility as well as assisted reproductive technologies may also be linked to altered methylation of Nanog and Oct4 promoters. The results suggest a correlation between PCOs and Oct4 methylation in oocytes. This finding needs to be confirmed by analyses on a larger number of patients.
Nuclear transplantation experiments have shown that selective DNA demethylation of the promoter is absolutely necessary for Oct4 transcription and that it operates independently of DNA, RNA and protein synthesis (Simonsson and Gurdon, 2004) . Thus, to be expressed in the early morula stage, the paternal allele probably undergoes reprogramming following fertilization, including a loss of DNA methylation (Chambers et al., 2003; Mitsui et al., 2003) . Conversely, Oct4 is down-regulated by hypermethylation as observed in normal human placenta (Zhang et al., 2008) . These authors also observed hypermethylation of Oct4 in androgenic hydatiform moles, reflecting the absence of demethylation of the Oct4 paternal alleles. Down-regulation of Oct4 and Nanog during human neuronal differentiation is correlated with dynamic sequential methylation of CpG residues in both promoter regions, and Deb-Rinker et al. (2005) proposed that DNA methylation ensures a long-term silencing of the two genes.
In control blastocyst ICM and in the majority of control 4-cell embryos, Oct4 and Nanog were hypomethylated, but some 4-cell embryos exhibited high methylation, particularly at Oct4 promoter, and in heterozygous embryos this hypermethylation of Oct4 can affect both the G21 or A21 allele type, one likely to be inherited from the father and the other from the mother. In human embryos, the remethylation of the genome starts at the blastocyst stage, thus the high methylation observed in some embryos is likely to correspond to an inherited methylation from the sperm or less frequently from the oocytes which was not erased during the wave of global demethylation of the genome following fertilization and which was transmitted through the first cell cycles to the zygote. In addition, embryos which reach normally the 4-cell stage at Day 2 and were cryopreserved may not be correctly remodelled at the epigenetic level and this could restrict their further development. This highlights the difficulty to get proper controls in human embryo studies.
In arrested embryos, the Nanog promoter appeared unmethylated in most embryos, while the Oct4 promoter was highly methylated in the majority of the embryos, independently of the number of cells. As observed among highly methylated control embryos, both the paternally and the maternally inherited alleles could be methylated in those embryos bearing the two types of alleles, G21 or A21. Considering the maternal allele, it implies that Oct4 mRNA may be absent in oocytes the promoter of which is hypermethylated. This hypothesis has to be checked. In humans, Oct4 is expressed in oocytes from stages GV to MII and in all stages of preimplantation development, from 2-cell to blastocyst stages (Cauffman et al., 2005) . In the mouse, Oct4 has been attributed a key role in the establishment of the developmental competence of oocytes, as the absence of Oct4 was associated with developmentally incompetent oocytes beyond the 2-cell stage (Zuccotti et al., 2008) . Oct4 positively regulates Stella, a maternal-effect factor required for the oocyte-to-embryo transition (Payer et al., 2003) and Stella protein was absent in these oocytes which are devoid of Oct4 and developmentally incompetent. Thus, the methylation of the Oct4 promoter in oocytes may induce the down-regulation of Oct4/Stella which may probably compromise their developmental competence. The higher degree of residual methylation in the Oct4 promoter compared with the Nanog promoter in early embryos has also been observed in other mammals. At the time of ZGA (zygotic genome activation), between 8-cell and morula stages in bovine, the Oct4 promoter appears more methylated (25.2%) than the Nanog promoter (3.8%) in in vitro fertilized bovine embryos (Lan et al., 2010) . On the other hand, the Nanog function requires the continued presence of Oct4 (Cavaleri and Scholer, 2003) and it was shown to regulate the G1 to S phase transition in human embryonic stem cells through direct binding to the cell cycle regulatory components CDK6 and CDC25A . In both control and arrested embryos, we could not make any correlation between the hypermethylation of Oct4 promoter and a particular cause of infertility. However, the significantly higher level of the Oct4 promoter methylation in embryos from couples with male known infertility, while oocytes from these couples were rather hypomethylated, would suggest that the paternal allele of the Oct4 promoter was particularly resistant to demethylation in this group of patients. Further investigation on the nuclear proteins associated with Oct4, particularly in sperm, would be helpful to understand the mechanisms involved. Anyhow, we have shown for the first time that embryos with early developmental failure, compared with control embryos, have significant hypermethylation of Oct4 promoter.
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